Security readout for executives and security teams
Plain-English summary
CVE-2019-25029 is a command injection issue in Versa Director. If reachable and vulnerable, an attacker may be able to make the application run operating system commands with the application's privileges. Business urgency is meaningful because Director is a management platform, but the source bundle does not provide CVSS, prerequisites, or confirmed exploitation.
Executive priority
Prioritize remediation for internet-reachable or broadly reachable Versa Director deployments. Treat as high priority because command injection can undermine a management system, while noting that the source bundle lacks CVSS, exploit prerequisites, and active exploitation evidence.
Technical view
The CVE describes CWE-77 command injection caused by insufficient input validation before user-supplied data is passed to a system shell. The affected product is Versa Director, with fixed versions listed as 16.1R2S11, 20.2.2, 21.1.1, and 21.2.1. Endpoint, authentication, and vulnerable version-range details are not included in the bundle.
Likely exposure
Exposure is likely limited to organizations running Versa Director before the listed fixed releases. Risk is highest where Director interfaces are reachable from untrusted networks or broad internal user populations. The bundle does not identify exact vulnerable builds, affected endpoints, or whether authentication is required.
Exploitation context
The bundle does not show CISA KEV listing or any cited evidence of active exploitation. A public HackerOne report is referenced, but the provided sources do not include exploit steps, weaponization status, or observed attacker activity.
Researcher notes
Key gaps are authentication requirements, vulnerable endpoints, exact affected version ranges, and privilege context. Use the CVE record and HackerOne reference to guide validation, but avoid assuming exploitation details not present in the supplied evidence.
Mitigation direction
- Upgrade Versa Director to a listed fixed version or later vendor-supported release.
- Restrict Versa Director management access to trusted administrative networks only.
- Review Versa vendor guidance and the HackerOne reference for environment-specific remediation details.
- Monitor Versa Director logs for unexpected administrative activity or command execution indicators.
Validation and detection
- Inventory all Versa Director instances and record exact version and build numbers.
- Confirm each instance is at or beyond 16.1R2S11, 20.2.2, 21.1.1, or 21.2.1.
- Verify management interfaces are not exposed to the public internet.
- Check whether compensating access controls cover all administrative entry points.
Public sources used
Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.
Conservative CVE-to-ATT&CK context
These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.
ATT&CK lookup starting points
Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.
CWE-77: Command execution behavior lookup
Command injection weaknesses can lead defenders to review execution techniques and command interpreter telemetry. Open the exact CWE lookup page first, then review the ATT&CK searches from that MITRE weakness context. This is a Glexia lookup hint, not an official ATT&CK mapping.
Open ATT&CK lookupExecution behavior lookup
The CVE wording references code or command execution, so execution technique review may help defensive triage. This is a Glexia inferred lookup path, not an official MITRE, ATT&CK, or CVE Program mapping.
Open ATT&CK lookupCVE-2019-25029 mapping review
Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.
Open ATT&CK lookup- Severity
- Unknown
- CVSS
- Not scored
- Known Exploited
- No
- Published
CNA and ADP enrichment extracted from CVE v5
These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.
CVSS and timeline data
No CVSS vectors or timeline events were available in the normalized CVE source material.
Source materials
- CVE List V5 sourceCVE List V5
- https://hackerone.com/reports/1168198CVE reference · x_refsource_MISC
Products and packages named in the record
CWE details
CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.
Improper Neutralization of Special Elements used in a Command ('Command Injection')
Improper Neutralization of Special Elements used in a Command ('Command Injection') represents a recurring weakness pattern that can create exploitable paths when design, validation, or implementation controls are missing.